Washington: Exposure to the virus that causes common cold can provide protection against infection by the SARS-CoV-2 virus behind COVID-19, according to a study. These genes trigger early-response molecules in the immune system which can stop reproduction of the SARS-CoV-2, the virus that causes COVID-19, within airway tissues infected with the cold, the researchers said. Triggering these defences early in …
Zydus Cadila has received emergency use approval from the Indian regulator for the use of its anti-viral drug 'Virafin'. Pharma giant Zydus says 91.15 per cent of adult patients treated with Virafin tested negative using RT-PCR in seven days. Virafin helps body cope with Interferon Alpha deficiency In its Phase III clinical trials, researchers found that a higher proportion of …
Zydus Cadila's Pegylated Interferon alpha-2b drug, 'Virafin', has received Emergency Use Approval from DCGI, the Drugs Controller General of India. Pharma giant Zydus Cadila says its anti-viral drug Virafin can not only reduce the need for medical oxygen but also improve recovery time among Covid-19 patients. Earlier launched as PegiHep, the drug was being used to treat Hepatitis C. A …
Hong Kong’s top pandemic doctor sees a way out of intensive care for thousands of Covid-19 patients: keeping them from entering in the first place. Yuen said he wasn’t surprised by the results of the WHO’s study because the drugs weren’t administered soon after patients became ill. “No antiviral will work if given late,” he said. “We need early cocktail …